|
As the lot number for the device was provided, a manufacturing review will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.(expiration date: 07/2023).
|
|
It was reported that during port device implant, the introducer needle allegedly broke in the patient.It was further reported that imaging allegedly identified pneumothorax.Reportedly, the broken part of the needle was removed and intervention was required to remove the port device.The patient was reported as stable.
|
|
It was reported that during port device implant, the introducer needle allegedly broke in the patient.It was further reported that imaging allegedly identified pneumothorax.Reportedly, the broken part of the needle was removed and intervention was required to remove the port device.The patient was reported as stable.
|
|
H10: manufacturing review: a lot history review was completed, which identified that this is the first complaint reported for this lot number.Therefore, the design history review is not required.Investigation summary: one introducer needle was returned for evaluation.Visual, microscopic and dimensional testing were perform.The needle was broken just distal to the needle hub.The distal needle segment was bent.Blood was noted on the sample.The investigation is confirmed for the alleged breaking of the needle cannula.The definitive root cause could not be determined based upon available information.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) showed that the product labeling is adequate.H10: d10, g4 h11: h3, h6 (method 1, results 1, conclusion 1) h11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|